For your technically curious: Retatrutide can be a synthetic peptide created for the moment-weekly dosing, with a half-lifetime of about six days. It's built on the GIP peptide backbone which is most potent in the GIP receptor, moderately powerful at GLP-1, and mildest on the glucagon receptor.